Seasonal mTOR Inhibitors May Reduce Winter Deaths
D
Dr. Joan Mannick on InsideTracker's Channel
ImmunityMedical
“Peaks of death during winter cold and flu season suggest potential for treatment.”
Story of claim
Dr. Mannick suggests using mTOR inhibitors during winter to reduce virus-related deaths in older adults by enhancing antiviral immunity.
- Goal: Reduce virus-related deaths during winter using mTOR inhibitors.
- Proof: Seasonal use of mTOR inhibitors could enhance immunity, reducing winter infection peaks.
- Nuances:
- mTOR inhibitors could be used seasonally to enhance immunity.
- Failed phase three trial highlights challenges in drug development.
- Impact on Life: Improved seasonal health with potentially fewer winter-related illnesses and hospital visits.
Investments
- Price: $50-100 per month during winter months
- Time: Seasonal use with gradual effects over winter
- Effort: Requires seasonal commitment and health tracking
Risks
Potential side effects of mTOR inhibitors necessitate careful medical supervision.
Alternatives
- Seasonal flu vaccinations and winter health precautions
Get Started 🚀
- Evaluate the benefits of mTOR inhibitors with a healthcare provider.
- Target use during winter for maximum effect.
- Adopt a regimen under medical guidance.
- Monitor health and adjust dosage as needed.
Brogevity AI can make mistakes. Check important info.